April 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreApril 21, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreApril 21, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreApril 21, 2026
The miRNA sequencing and assay market is growing with advancements in next-gen sequencing (NGS) to explore miRNA's role in gene regulation and disease. Recent funding rounds, like aceRNA's $6.1M raise and Regulus' $100M deal, highlight innovations. AI integration, like Biostate AI's RNAseq tools, further accelerates research....
April 21, 2026
RNA-based therapies are rapidly growing, offering new treatment possibilities for diseases like cancer, neurological disorders, and infections. Recent advancements in mRNA, ASO, and siRNA technologies have led to new approvals, with more in development. These therapies offer targeted, risk-free solutions with broad potential....
April 21, 2026
Based on market forecasts, the global cell counting market, projected at USD 10.24 billion in 2024, is expected to reach USD 22.85 billion by 2034, growing at a CAGR of 8.41% over the forecast period. The cell counting market is growing because incorporating cell counts into flow cytometry is an easy way to improve test results and potentially save...
April 21, 2026
Market insights predict the global automated sample storage systems industry will increase from USD 1.42 billion in 2025 to USD 4.12 billion by 2035, achieving a CAGR of 11.24%. Automated sample storage systems use advanced technology to store biological and chemical samples at ultra-low temperatures. These systems ensure sample integrity, streamli...
April 21, 2026
According to market projections, the glycomics sector is expected to grow from USD 2.21 billion in 2024 to USD 8.66 billion by 2034, reflecting a CAGR of 14.64%. The glycomics field is growing significantly due to its applications in drug discovery, disease diagnosis, therapeutics, and personalized medicine....
April 21, 2026
Induced pluripotent stem cells (iPSCs) are versatile cells derived from adult skin or blood, capable of transforming into any cell type. Widely used in regenerative medicine, disease modeling, and drug discovery, iPSCs are driving innovation, fueled by rising R&D and investment in stem cell therapies....
April 21, 2026
Market insights predict the global stroke management industry will increase from USD 44.82 billion in 2025 to USD 91.86 billion by 2035, achieving a CAGR of 7.44%. The stroke management market is growing rapidly, driven by advancements in emergency treatments for ischemic and hemorrhagic strokes. Innovations like argatroban improve outcomes, while ...
April 21, 2026
The macular edema and macular degeneration market is growing rapidly due to the prevalence of diabetic retinopathy and advancements in treatments like gene therapy and AI-based devices. Innovations, including FDA-approved EYLEA HD and OrCam MyEye, highlight progress in addressing vision loss globally....
April 21, 2026
Tissue clearing is a technique that makes biological tissues transparent for better microscopy visualization. Combined with fluorescent labeling and advanced imaging, it enables detailed 3D analysis. AI enhances this process by improving tissue imaging, data analysis, and accelerating research in fields like cancer and neurology....
April 21, 2026
The multiomics market is advancing with key funding rounds: PrognomiQ raised $34M (Nov 2024) to enhance disease monitoring, and Freenome secured $254M (Feb 2024) for early cancer detection tests. AI integration drives breakthroughs in data analysis, precision medicine, and drug discovery (e.g., MultiOmic Health)....